• Chlorin e6 (Ce6): Reliable PDT Assay Design

  2026-09-12

  Learn how Chlorin e6 (Ce6), SKU B8314, can improve control of light-dependent cytotoxicity, stock preparation, and mechanistic interpretation in cell assays. This scenario-based guide connects product specifications with published evidence on reactive oxygen species generation, apoptosis, pyroptosis, and anticancer photodynamic therapy.

• PrLGlu/avBNSTGABA Circuit in Depression-Like Behavior

  2026-09-11

  The reference study identifies a projection-defined prelimbic cortex to anterior ventral BNST circuit that rapidly reduces depression-like behaviors in male mice when activated. Its combination of causal circuit manipulation, AMPAR pharmacology, and ketamine-sensitive activity measurements links circuit function to rapid antidepressant mechanisms while also defining important limits for translation.

• Targeting Fructose Metabolism in Cancer

  2026-09-11

  The 2025 Cancer Letters review positions fructose metabolism as a metabolic and signaling dependency associated with aggressive cancer phenotypes. By integrating transporter biology, the endogenous polyol pathway, cancer statistics, and therapeutic concepts, it provides a framework for studying fructose use as a potential vulnerability rather than treating it as a secondary nutrient effect.

• Plerixafor (AMD3100): An Assay-First CXCR4 Guide

  2026-09-10

  Explore how Plerixafor (AMD3100) can function as a mechanistic benchmark for CXCR4 and CXCL12 research. This assay-first guide connects receptor pharmacology with cancer metastasis inhibition, stem cell mobilization, and interpretation of emerging CXCR4 inhibitors.

• Selective Autophagy Tunes IRF3 Stability and IFN

  2026-09-10

  Wu and colleagues show that CALCOCO2/NDP52-mediated selective autophagy degrades IRF3 in a virus-load-dependent manner, while PSMD14 preserves basal IRF3 through deubiquitination of a K27-linked ubiquitin signal at lysine 313. The work connects ubiquitin editing, autophagic cargo selection, and type I interferon output, providing a mechanistic explanation for how antiviral signaling is restrained without being eliminated.

• Guanabenz Acetate in GPCR Research

  2026-09-09

  Guanabenz Acetate enables subtype-resolved α2-adrenergic receptor experiments with a practical DMSO-based workflow. This guide connects receptor pharmacology to a carefully bounded, hypothesis-driven assay strategy inspired by SARS-CoV-2 stress-granule research.

• Capsazepine Workflows for TRPV1 Research

  2026-09-09

  Capsazepine is a practical pharmacological probe for separating TRPV1-dependent calcium signaling and nociception from downstream inflammatory effects. This guide connects concentration-aware channel assays with pain-model controls, TRPM8 selectivity checks, and exploratory apoptosis sensitization studies.

• Sorafenib in Liver Cancer Research Workflows

  2026-09-08

  Build reproducible Sorafenib workflows for RAF/MEK/ERK signaling, tumor proliferation inhibition, and angiogenesis studies in liver cancer models. This guide also shows how to use Sorafenib as a mechanistic benchmark alongside mitochondrial cholesterol and mitophagy assays inspired by recent celastrol research.

• A1 and CXCR4 Inhibition in Colorectal Cancer

  2026-09-08

  Khorramdelazad et al. evaluate A1, a fluorinated CXCR4 inhibitor, through molecular dynamics, CT-26 cell experiments, and a BALB/c colorectal cancer model. A1 showed more favorable calculated CXCR4 binding than AMD3100 and produced stronger effects on tumor growth, migration, regulatory T-cell infiltration, and immunosuppressive signaling in vivo, while remaining a preclinical candidate requiring further validation.

• Guanabenz Acetate in Receptor and Stress Assays

  2026-09-07

  Guanabenz Acetate provides a subtype-aware way to perturb α2-adrenergic signaling while monitoring stress-granule and innate-immune phenotypes. This workflow connects receptor pharmacology with the GADD34–IRF3 biology reported in SARS-CoV-2 research, while clearly separating established evidence from testable assay hypotheses.

• AO/PI Staining Solution for Accurate Cell Counting

  2026-09-07

  AO/PI Staining Solution uses two fluorescent DNA dyes to distinguish cells with intact membranes from cells with compromised membranes. The K2269 reagent supports fluorescence-based cell counting and can reduce debris and red-blood-cell interference when the workflow is validated with appropriate controls.

• Phillygenin in Diabetic Nephropathy: Mechanistic Evidence

  2026-09-05

  The reference study shows that phillygenin protects against diabetic kidney injury in high-glucose podocytes and db/db mice by suppressing TLR4/MyD88/NF-κB-associated inflammation and supporting PI3K/AKT/GSK3β signaling. Its integrated use of RNA sequencing, cellular assays, biochemical readouts, histology, and animal studies provides a useful preclinical framework for connecting podocyte apoptosis with albuminuria.

• Matrine, YTHDF1, and Thymoma Stemness

  2026-09-04

  A 2026 study connects Matrine treatment with reduced stemness-associated behavior and increased apoptosis in EL-4-B5 thymoma cells, implicating YTHDF1 and Wnt/β-catenin signaling. The work offers a focused assay framework for thymoma research, while its single-model design and lack of direct m6A, in vivo, and clinical validation require cautious interpretation.

• Guanabenz Acetate in Receptor Signaling Workflows

  2026-09-04

  Guanabenz Acetate provides a practical way to resolve α2a-, α2b-, and α2c-adrenergic receptor responses in concentration-controlled GPCR assays. This guide connects receptor pharmacology with stress-granule and innate-immune readouts while clearly separating established evidence from hypothesis-generating applications.

• Capsazepine Workflows for TRPV1 Research

  2026-09-03

  Capsazepine provides a practical pharmacological switch for separating TRPV1-driven calcium signaling and nociception from TRPM8, calcium-current, and apoptosis-related effects. This workflow guide translates receptor pharmacology and a recent multimodal pain study into assay design, controls, and troubleshooting decisions.

7936 records 1/530 page Next 12345 下5页 Last page